DB15172InvestigationalProtein Based Therapies
Suvratoxumab is under investigation in clinical trial NCT02296320 (Study of the Efficacy and Safety of MEDI4893).
- Code names
- MEDI4893
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Suvratoxumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account